Videos

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men's treatment decisions after seeing a rise in their PSA levels.

This National Cancer Institute video provides key facts and statistics on prostate cancer diagnosis and treatment.

This presentation by Michael S. Cookson, MD, MMHC, vice chairman and Hart Professor of Urologic Surgery at Vanderbilt University Medical Center, addresses prostate cancer treatment options for 6 common clinical scenarios.

Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting.

Nancy Lin, MD, of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.

This presentation by Carol DeSantis, MPH, an epidemiologist with the American Cancer Society (ACS), covers key findings and statistics from the ACS report "Breast Cancer Facts and Figures 2013-2014."

In this video, Douglas Lienesch, MD, assistant professor in the division of rheumatology and clinical immunology at the University of Pittsburgh Medical Center, offers an overview of available medications for the treatment of psoriatic arthritis.

Philip Mease, MD, director of rheumatology research at Swedish Medical Center and clinical professor at the University of Washington School of Medicine in Seattle, discusses key points regarding the diagnosis and treatment of psoriatic arthritis in this video produced by the Cleveland Clinic Center for Continuing education.

In this video produced by the National Psoriasis Foundation, experts offer their insights into improving outcomes for psoriatic arthritis patients.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses the questions specialty providers need to address to reach consumers in the changing health care landscape.

Deborah Cmielewski, Esq., vice president and general counsel at Armada Health Care, discusses key issues regarding HI-Tecj/HIPAA legislation for specialty pharmacies.

Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses how all pharmacies can manage diabetes patients.

Leigh Ann Bruhn, director of Avalere Health, discusses how specialty pharmacies can help achieve the goals of accountable care groups.

Michael Einodshofer, RPh, MBA, senior director of specialty strategy and innovation at Walgreens, discusses the potential impact of specialty medications on overall drug spending.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses emerging trends in the treatment of cancer that specialty pharmacies need to be aware of.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, director of clinical programs at the Illinois Pharmacists Association, discusses how pharmacists personalize and enhance care for diabetes patients.

Shannon Ambrose, senior director of Specialty Solutions at Prime Therapeutics, discusses the factors that negatively impact medication adherence for specialty drugs.

Stephen Vogt, PharmD, Chief Executive Officer and President of BioPlus Specialty Pharmacy, discusses the ongoing debate surrounding the high price of Hepatitis C treatments versus the efficacy of the drug.

Acid reflux is frequently dismissed as a nuisance, but can lead to serious damage to the stomach and esophagus if not properly treated.

C. Daniel Smith, MD, chair of the surgery department at the Mayo Clinic in Florida, discusses a bracelet-like device with magnetic beads that is designed to control acid reflux.

Jeremy Schafer, PharmD, MBA, Senior Director of Specialty Solutions and Manufacturer Relations at Prime Therapeutics, discusses new developments in medication adherence for specialty pharmacy.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the training pharmacists should pursue if they are interested in playing a role in patient-centered diabetes care.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses challenges for specialty pharmacy in the management of patients with multiple sclerosis.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses developments in the treatment of lung cancer that specialty pharmacies need to be aware of.

Catamaran Corporation Senior Vice President of Pharmacy Operations and Industry Albert Thigpen discusses the impact from the high cost of specialty medications on overall drug spending in 2014.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Shannon Manzi, PharmD, EMT, describes the sort of training given to pharmacists who serve on disaster medical assistance teams.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the range of education and training that prepares pharmacists to play a role in patient-centered diabetes care.

Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, discusses how HIPAA laws could change the use of electronic adherence tools.

David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses changes in insurance reimbursement for compounded medications.